Carnegie Mellon University researchers advance Structure-Based RNA targeting for Neuromuscular Disorders, including myotonic dystrophy type 1.
Purdue researchers develop LENN, an mRNA Delivery System targeting Bladder Cancer cells to advance nucleic acid therapies without immune activation.
JCI Insight study finds a Nasal COVID Booster enhances variant neutralization by reprogramming immunity from intramuscular vaccines to produce stronger nasal antibodies.
Review in the *New England Journal of Medicine* highlights a shift in sports cardiology, showing many athletes can return after cardiac arrest.
Meta-analysis finds a shared brain alteration in schizophrenia and bipolar disorder, with École Polytechnique Fédérale researchers supporting a psychosis spectrum.